| 标题 |
460MO Preliminary results from a phase I study using the bispecific, human epidermal growth factor 2 (HER2)-targeting antibody-drug conjugate (ADC) zanidatamab zovodotin (ZW49) in solid cancers |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:Komal Jhaveri; Hyo S. Han; Efrat Dotan; D-Y. Oh; C. Ferrario; et al 出版日期:2022-09-01 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)